HIV-infected Participants With Latent TB Infection in High TB Burden Country

Clinical trial pipeline · Data from ClinicalTrials.gov

See which HIV-infected Participants With Latent TB Infection in High TB Burden Country trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Active — Not RecruitingPhase 3

NCT03785106

Tuberculosis Preventive Therapy Among Latent Tuberculosis Infection in HIV-infected Individuals

The investigators want to know if ultra-short, effective treatment for latent tuberculosis (TB) infection (LTBI) could dramatically reduce the global incidence…

Thailand2,500 participantsStarted 2019-08-15

Treatment: Isoniazid/Rifapentine daily (4 weeks) plus pyridoxine (vitamin B6), Isoniazid/Rifapentine 12-weekly plus pyridoxine (vitamin B6)